According to Phibro Animal Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.533304. At the end of 2023 the company had a P/S ratio of 0.4776.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.4776 | -14.52% |
2022 | 0.5588 | -40.59% |
2021 | 0.9405 | -4.47% |
2020 | 0.9845 | -20.28% |
2019 | 1.23 | -20.22% |
2018 | 1.55 | -9.85% |
2017 | 1.72 | 11.87% |
2016 | 1.53 | -2.46% |
2015 | 1.57 | -6.16% |
2014 | 1.68 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Eli Lilly LLY | 21.7 | 3,964.38% | ๐บ๐ธ USA |
Archer Daniels Midland (ADM)
ADM | 0.3419 | -35.89% | ๐บ๐ธ USA |
Zoetis ZTS | 9.07 | 1,600.32% | ๐บ๐ธ USA |
Merck MRK | 5.56 | 942.39% | ๐บ๐ธ USA |
Kindred Biosciences
KIN | N/A | N/A | ๐บ๐ธ USA |
Heska Corporation
HSKA | 5.14 | 863.38% | ๐บ๐ธ USA |